#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Eosinophilic oesophagitis Pustular psoriasis Cushing's syndrome Biliary cancer metastatic Hyperinsulinaemic hypoglycaemia Anal squamous cell carcinoma Juvenile idiopathic arthritis Parkinson's disease Extra-osseous Ewing's sarcoma Interstitial lung disease Epilepsy with myoclonic-atonic seizures Albright's disease Angelman's syndrome Hepatocellular carcinoma Hidradenitis More trials…

    Learn about Rare Diseases

    Hypereosinophilic syndrome Chronic granulomatous disease – Life with Disease Mantle cell lymphoma – Treatment Choroid melanoma – Basic Information Nephrotic syndrome – Treatment Myxofibrosarcoma Uterine leiomyosarcoma – Diagnostics Mantle cell lymphoma refractory – Life with Disease Waldenstrom’s macroglobulinaemia refractory – Trials in Disease Systemic sclerosis pulmonary – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fenfluramine Hydrochloride INCB123667 Iti-1284 Mannitol Incb099280 Fentanyl Silibinin Aluminium Oxide, Hydrated Betula Verrucosa Pollen Cebsulfase Alfa Fexofenadine Ataluren Trazodone INOBRODIB Azacitidine Bendamustine Dexamethasone Ph. Eur. Pyrazinamide GSKVX000000025896 Esflurbiprofen More therapies…

    Learn about Your Condition

    Organ donor Depression Cutaneous calcification Richter's syndrome Anal fistula Labour pain Liver disorder Prostatitis Escherichia coli Chronic coronary syndrome Biliary tract disorder Psychotic disorder Impaired gastric emptying Primary myelofibrosis Malignant lymphoid neoplasm Arterial stiffness More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Diffuse large B-cell lymphoma

  • Study on the Effectiveness and Safety of Polatuzumab Vedotin, Rituximab, and CHP in Patients with Untreated Diffuse Large B-Cell Lymphoma

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Polatuzumab Vedotin
    • Rituximab
    • Vinorelbine
    Austria Belgium Czechia France Germany Italy +2

  • Study of Brentuximab Vedotin Combined with R-DHAP Chemotherapy for Patients with Relapsed or Treatment-Resistant CD30-Positive Diffuse Large B-Cell Lymphoma Who Are Eligible for Stem Cell Transplant

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    • Non-Hodgkin’s lymphoma
    Investigated Drugs:
    • Brentuximab Vedotin
    Belgium The Netherlands Spain

  • Study on Prednisone and Vitamin D for Elderly Patients with Diffuse Large B-Cell Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Colecalciferol
    • Glycerol
    • Prednisolone
    Italy

  • PET Imaging with 89Zr-Atezolizumab in Patients with Large B-cell Lymphoma Undergoing CD19 CAR T-cell Therapy

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Atezolizumab
    The Netherlands

  • Study Comparing Polatuzumab Vedotin with Rituximab, Ifosfamide, Carboplatin, and Etoposide for Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    • B-cell lymphoma
    • Diffuse large B-cell lymphoma refractory
    Investigated Drugs:
    • Etoposide Phosphate
    • Ifosfamide
    • Polatuzumab Vedotin
    Austria Germany Spain

  • Study Comparing Loncastuximab Tesirine and Rituximab with Standard Treatment for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Loncastuximab Tesirine
    • Dexamethasone
    • Gemcitabine
    Belgium Czechia France Hungary Italy The Netherlands +2
Previous Page
1 … 3 4 5 6 7 … 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!